Stock Of the Day
Dec 30, 2025
by PATRICK SEITZNova (NVMI) is the IBD Stock Of The Day as the supplier of semiconductor manufacturing equipment sees strong business related to the artificial intelligence megatrend.
The Israel-based company provides advanced metrology and process control solutions used in chipmaking.
Cantor Fitzgerald analyst Matthew Prisco rates Nova stock as overweight, or buy, with a price target of 420.
In a Dec. 16 report, Prisco said he favors Nova as a “long-term investment” because of its “unique offering” and exposure to leading-edge chip manufacturing.
Dec 29, 2025
by RYAN DEFFENBAUGHReddit (RDDT) is the IBD Stock of the Day for Monday. Shares of the social media company are approaching a cup-with-handle buy point while holding above a short-term moving average.
San Francisco-based Reddit’s social media platform features more than 2 billion posts across more than 100,000 communities. Reddit stock soared out of the IPO gate with a more than 600% rally over the 18 months following its March 2024 debut. Shares opened Monday about 19% below a record high from September, but are still on track to close 2025 with a roughly 40% gain.
Dec 26, 2025
by JUAN CARLOS ARANCIBIALas Vegas Sands (LVS) is the IBD Stock of the Day as shares of the resort operator trade constructively tight and above an important chart level.
Despite its name, the company no longer owns any hotels or casinos in Las Vegas. Instead, it’s become the leading casino resort operator in Macao, China’s gambling district. It operates five integrated resorts in Macao, where the company’s projects such as the $5.6 billion Marina Bay Sands helped turn the area into a gaming destination.
Dec 24, 2025
by PATRICK SEITZArtificial intelligence enabler Nvidia (NVDA) is the IBD Stock Of The Day as the chipmaker prepares to start the new year with announcements at the CES 2026 tech trade show in Las Vegas.
Nvidia Chief Executive Jensen Huang is scheduled to give a media briefing at 1 p.m. Pacific time on Jan. 5 at the show. He will provide an update on Nvidia’s business outlook and product roadmap for the year ahead.
Dec 23, 2025
by REINHARDT KRAUSEShopify (SHOP) is the IBD Stock Of The Day as the e-commerce software and services provider expands from its roots in the small and medium-size business markets. Shopify stock has gained 59% in 2025.
On the stock market today, Shopify stock dipped a fraction to close at 169.53. However, Shopify stock has forged a cup base with a buy point of 182.19, according to MarketSurge charts. Aggressive investors could look for an early entry around 169, but Shopify’s chart is messy.
Dec 22, 2025
by JUAN CARLOS ARANCIBIADefense contractor RTX (RTX) is trading in a buy zone as the company takes advantage of tailwinds in military and commercial markets. One of a number of defense stocks acting well, RTX is the IBD Stock of the Day.
RTX, the nation’s largest defense company, is sitting on a $251 billion backlog as military spending grows and commercial aviation provides another solid path to continued growth.
As European nations boost defense spending and geopolitical risks simmer, the outlook for military contractors is favorable. The iShares U.S. Aerospace & Defense ETF (ITA) is up 50% this year and is close to breaking out to new highs.
Dec 19, 2025
by PATRICK SEITZLam Research (LRCX) is the IBD Stock Of The Day as the semiconductor equipment maker is called a “best-in-class franchise.” LRCX stock notched a record high on Friday.
Oppenheimer analyst Edward Yang on Friday reiterated his outperform, or buy, ratings on Lam Research and KLA (KLAC). He said the semiconductor capital equipment firms are heading into 2026 “on strong footing.”
From an investment perspective, Yang is focused on “best-in-class franchises/compounders” among semicap firms and cited Lam and KLA.
Dec 18, 2025
by ALLISON GATLINEli Lilly (LLY) is Thursday’s IBD Stock Of The Day after the company proved the merit of its weight-loss pill as a maintenance treatment. Shares are bouncing off their 21-day line, clearing a short-lived pause.
In a yearlong study, patients who switched to orforglipron from injectable drugs maintained most of the weight they initially lost from injectable drugs, Eli Lilly said in a news release.
The study is the first of its kind. Patients initially lost weight during 72 weeks of treatment with the highest doses of Novo Nordisk’s (NVO) Wegovy or Lilly’s Zepbound. Then, they switched to orforglipron for 52 weeks. Orforglipron delivered “superior weight management as an adjunct to a healthy diet and physical activity” compared with a placebo.
Dec 17, 2025
by RYAN DEFFENBAUGHPalantir Technologies (PLTR) is the IBD Stock Of The Day for Wednesday. Despite a solid intraday decline, shares of the data analytics software company have formed a cup base with their rebound in December. Palantir stock slid 16% last month.
On the stock market today, Palantir stock fell 5.6% to close at 177.29. Shares have gained more than 5% in December following a slump last month and remain ahead more than 137% so far this year.
Dec 16, 2025
by JUAN CARLOS ARANCIBIAWith electricity demand surging, grid-consulting firm Willdan Group (WLDN) has emerged as a growth story. The IBD Stock Of The Day is near a buy point, even as other data center stocks weaken.
Willdan specializes in technical and advisory services for the transition to clean energy and for maximizing electric infrastructure. After years of minor load growth, electricity demand is growing at the fastest rate in decades. An analysis from Willdan subsidiary E3 sees U.S. electric use rising 1.1% to 2.2% annually through 2035, driven by electric vehicles, heat pumps, manufacturing and, especially, data centers.